top of page
  • Think News Online

FDA cautions public against purchase, usage of DIABOOST pills

The Food and Drugs Authority (FDA) has cautioned the general public to desist from purchasing and using DIABOOST, a product that is said to kill diabetes and normalizes blood sugar levels after first use, among others.


According to the FDA, it has not registeredor approved of DIABOOST to be sold to the general public.


In a communique signed by its Chief Executive Officer (CEO), Dr. Delese Mimi Darko, she said "The Food and Drugs Authority (FDA) has detected the presence of an unregistered product, DIABOOST, being marketed on social media, by 36TY Courier Services, located at Ritz Junction, Madina"


"The product is being marketed as a product that kills diabetes and normalizes blood sugar levels after first use, among others."


The FDA stressed that claims by the DIABOOST pills are false.


"The product is in fact labelled as a food supplement, not a medication and thus cannot be used in the treatment of diabetes"


"DIABOOST is not registered by the FDA. For this reason, its

efficacy, quality, and most importantly, safety for diabetics cannot be guaranteed by the Authority"


The Authority has advised all diabetics to strictly adhere to

prescribed treatment by their doctors and discuss any alternative treatment with them as well to avoid any complications.


DIABOOST is manufactured in Bulgaria for SPB, REALTY LTD, 1 HAN ASPARUH STR., BURGAS, BULGARIA and distributed in

Ghana by 36TY Courier Service, headed by Ms. Mary Alimena,

who is currently assisting the Police with the investigation.


The FDA says it is by this notice asking all persons who have the product to stop using them immediately and return them to the nearest FDA office or to the supplier.


The Authority wishes to encourage the public to check the

registration status of all regulated products from the FDA website, www.fdaghana.gov.gh and the ProPer Platform

(https://bit.ly?ProPerFDA-Verify) before purchase in order to avoid any harm.


Story by: Joshua Kwabena Smith

0 comments

コメント


bottom of page